Chemotherapy
498 articles
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Gut Reaction for Pancreatic Cancer
Dr. Florencia McAllister and her team are looking at the tumor microbiome to develop effective pancreatic cancer treatments.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.
How Could This Happen to Me?
Michael Bailey felt his world turn sideways after a diagnosis of acinar cell pancreatic cancer. He had a pancreatectomy and chemotherapy.
Genetic Profiling Leads to a Clinical Trial
With treatment not working and nothing to lose, Cathleen Janosko did her research and got help finding a clinical trial to match her tumor’s mutation.
Lots and Lots of Research Leads to a Better Outcome
Dan Grunfeld put his experience as a chemist to good use as he researched pancreatic cancer treatments to find a clinical trial.
Positive Results For Borderline Resectable Disease Pilot Study
Dr. Zev Wainberg provides details on a trial of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer.
No Time for Self-Pity
When David Smith started losing weight after a diabetes diagnosis, his daughter-in-law was concerned because she had seen this before.
Why Side Effect Management Matters More Than Ever
As an endo-oncologist, Dr. Afreen Shariff knows the importance of side effects in pancreatic cancer patients.
Choosing Chemo Because I Want to Live
After doing poorly on her first chemotherapy treatments, Catalina Lulley switched doctors because she is determined to survive pancreatic cancer.
Two-Year Survivor and Going Strong
Susan Hoopengarner coordinated her care between a local hospital and a major cancer center for chemotherapy and a Whipple procedure.
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.